Growth Metrics

Arcadia Biosciences (RKDA) Cash from Operations (2016 - 2025)

Arcadia Biosciences' Cash from Operations history spans 12 years, with the latest figure at 861000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 60.54% year-over-year to 861000.0; the TTM value through Dec 2025 reached 4739000.0, up 50.64%, while the annual FY2025 figure was 4739000.0, 50.64% up from the prior year.
  • Cash from Operations reached 861000.0 in Q4 2025 per RKDA's latest filing, down from 257000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 257000.0 in Q3 2025 to a low of 8268000.0 in Q3 2021.
  • Average Cash from Operations over 5 years is 3475350.0, with a median of 3287500.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: crashed 74.49% in 2023, then soared 85.33% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 6660000.0 in 2021, then soared by 64.28% to 2379000.0 in 2022, then tumbled by 74.49% to 4151000.0 in 2023, then skyrocketed by 47.43% to 2182000.0 in 2024, then skyrocketed by 60.54% to 861000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Cash from Operations are 861000.0 (Q4 2025), 257000.0 (Q3 2025), and 2033000.0 (Q2 2025).